您的位置: 首页 > 农业专利 > 详情页

Type II anti-CD20 antibody for reducing formation of anti-drug antibodies
专利权人:
F. Hoffmann-La Roche AG
发明人:
Bacac, Marina,Evers, Stefan,Klein, Christian,Pisa, Pavel,Rossmann, Eva,Saro, Jose,Umaña, Pablo
申请号:
AU2016368469
公开号:
AU2016368469A1
申请日:
2016.12.06
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention relates to methods of treating a disease, and methods for reduction of the formation of anti-drug antibodies (ADAs) in response to the administration of a therapeutic agent. The invention further relates to methods of treating a disease, particularly a B-cell proliferative disorder, and methods for reduction of adverse effects in response to the administration of a therapeutic agent, particularly a T-cell activating therapeutic agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充